## Abstract Parathyroid hormone (PTH) and glycogen synthase kinaseβ3 (GSKβ3) inhibitor 603281β31β8, administered once daily increased bone formation in vivo. We investigated the molecular mechanisms of the anabolic responses of PTH and 603281β31β8 in rat osteopenia model. Female 6βmonthβold rats we
Role of Bcl2 in osteoclastogenesis and PTH anabolic actions in bone
β Scribed by Junro Yamashita; Nabanita S Datta; Yong-Hee P Chun; Dong-Ye Yang; Allison A Carey; Jaclynn M Kreider; Steven A Goldstein; Laurie K McCauley
- Publisher
- American Society for Bone and Mineral Research
- Year
- 2011
- Tongue
- English
- Weight
- 33 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0884-0431
- DOI
- 10.1002/jbmr.383
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Parathyroid hormone (PTH) increases fibroblast growth factor receptorβ1 (FGFR1) and fibroblast growth factorβ2 (FGFβ2) expression in osteoblasts and the anabolic response to PTH is reduced in Fgf2β/β mice. This study examined whether candidate factors implicated in the anabolic response
## Abstract We have previously reported that Fasβresistant A20 cells (FasR) have phospholipase D (PLD) activity upregulated by endogenous PLD2 overexpression. In the present study, we investigated how overexpressed PLD2 in FasR could generate survival signals by regulating the protein levels of ant
## Abstract Teriparatide, human PTH (1β34), a new therapy for osteoporosis, elicits markedly different skeletal responses depending on the treatment regimen. In order to understand potential mechanisms for this dichotomy, the present investigation utilized microarrays to delineate the genes and pat